Fusion Antibodies plc (LON:FAB) Insider Adrian Kinkaid Buys 83,728 Shares

Fusion Antibodies plc (LON:FAB) insider Adrian Kinkaid purchased 83,728 shares of the company’s stock in a transaction on Wednesday, October 16th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £3,349.12 ($4,373.36).

Adrian Kinkaid also recently made the following trade(s):

• On Wednesday, September 4th, Adrian Kinkaid purchased 120,000 shares of Fusion Antibodies stock. The stock was purchased at an average price of GBX 3 ($0.04) per share, for a total transaction of £3,600 ($4,700.97).

Fusion Antibodies Price Performance

Shares of LON:FAB opened at GBX 4.90 ($0.06) on Thursday. The firm’s 50 day moving average is GBX 3.61 and its two-hundred day moving average is GBX 3.51. Fusion Antibodies plc has a 52 week low of GBX 2.80 ($0.04) and a 52 week high of GBX 9.50 ($0.12). The firm has a market capitalization of £4.67 million, a P/E ratio of -120.00 and a beta of 0.49. The company has a current ratio of 3.87, a quick ratio of 2.36 and a debt-to-equity ratio of 2.40.

Fusion Antibodies Company Profile

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services.